• 제목/요약/키워드: Medicine Prescription Data

검색결과 295건 처리시간 0.04초

ASP와 SQL을 연동한 사이버닥터의 지능형 전자진료차트와 데이터처리 (Intelligence Type Electronic Medical Examination Chart and Data Treatment of Cyber Doctor to Interconnect ASP and SQL)

  • 김석수
    • 디지털콘텐츠학회 논문지
    • /
    • 제4권1호
    • /
    • pp.57-66
    • /
    • 2003
  • 본 논문에서는 인터넷 기반에서의 3자(환자, 의사, 약사)간의 상호대화형 원격진료 시스템 구현으로서, 효율적인 진료와 빠른 처리를 위한 전자진료차트 및 자료처리에 관한 내용을 제시하고 있다. 즉, 고가형 시스템, 비호환성 등 기존 원격진료시스템의 문제점을 해결한 저가형이면서, 누구나 참여할 수 있는 웹상에서의 시공간을 초월한 on-line 및 off-line 겸용모드의 지능형 원격진료시스템이다. 데이터베이스는 IIS 4.0 웹서버상에서 ASP와 SQL을 연동한 구현하여 효율적인 자료처리를 위한 시스템 통합과 환자와 의사간의 on-line 상담, 그리고 off-line상에서의 진료와 환자가 지정한 약사로의 처방전 전송 및 조제, 그리고 진료데이터의 저장 및 검색으로 인한 반영구적인 진료데이터저장, 환자 및 의사의 본 진료데이터를 이용한 보다 정확한 진료 및 처방등이 가능하다.

  • PDF

한의 체중 조절 프로그램에 참여한 과체중, 비만 환자에서의 머신러닝 기법을 적용한 체중 감량 예측 연구 (Application of Machine Learning to Predict Weight Loss in Overweight, and Obese Patients on Korean Medicine Weight Management Program)

  • 김은주;박영배;최가혜;임영우;옥지명;노은영;송태민;강지훈;이향숙;김서영
    • 대한한의학회지
    • /
    • 제41권2호
    • /
    • pp.58-79
    • /
    • 2020
  • Objectives: The purpose of this study is to predict the weight loss by applying machine learning using real-world clinical data from overweight and obese adults on weight loss program in 4 Korean Medicine obesity clinics. Methods: From January, 2017 to May, 2019, we collected data from overweight and obese adults (BMI≥23 kg/m2) who registered for a 3-month Gamitaeeumjowi-tang prescription program. Predictive analysis was conducted at the time of three prescriptions, and the expected reduced rate and reduced weight at the next order of prescription were predicted as binary classification (classification benchmark: highest quartile, median, lowest quartile). For the median, further analysis was conducted after using the variable selection method. The data set for each analysis was 25,988 in the first, 6,304 in the second, and 833 in the third. 5-fold cross validation was used to prevent overfitting. Results: Prediction accuracy was increased from 1st to 2nd and 3rd analysis. After selecting the variables based on the median, artificial neural network showed the highest accuracy in 1st (54.69%), 2nd (73.52%), and 3rd (81.88%) prediction analysis based on reduced rate. The prediction performance was additionally confirmed through AUC, Random Forest showed the highest in 1st (0.640), 2nd (0.816), and 3rd (0.939) prediction analysis based on reduced weight. Conclusions: The prediction of weight loss by applying machine learning showed that the accuracy was improved by using the initial weight loss information. There is a possibility that it can be used to screen patients who need intensive intervention when expected weight loss is low.

병원 및 의원급 일일사용량 기준 항생제 사용량에 영향을 미치는 요인 (Analysis of factors affecting antibiotic use at hospitals and clinics based on the defined daily dose)

  • 이은지;이근우;박주희;김동숙;안형식
    • 대한의사협회지
    • /
    • 제61권11호
    • /
    • pp.687-698
    • /
    • 2018
  • Inappropriate antibiotic use significantly contributes to antibiotic resistance, resulting in reduced antibiotic efficacy and an increased burden of disease. The objective of this study was to investigate the characteristics of prescribers whose antibiotics use was high and to explore factors affecting the use of antibiotics by medical institutions. This study analyzed the National Health Insurance claims data from 2015. Antibiotic prescription data were analyzed in terms of the number of defined daily doses per 1,000 patients per day, according to the World Health Organization anatomical-therapeutic-chemical classification and methodologies for measuring the defined daily dose. We investigated the characteristics of prescribers and medical institutions with high antibiotic use. Multivariate regression analyses were performed on the basis of characteristics of the medical institution (number of patients, type of medical institution [hospital or clinic], age of the physician, etc.). The number of patients and number of beds were found to be significant factors affecting antibiotic use in hospitals, and the number of patients, region, and medical department were significant factors affecting antibiotic use at the level of medical institutions. These findings are expected to help policy-makers to better target future interventions to promote prudent antibiotic prescription.

백설풍(白屑風)의 외치법(外治法)에 대한 문헌적 고찰 (A Literature Study on the External Treatment of Seborrheic Dermatitis)

  • 이선용;정재호;서형식
    • 한방안이비인후피부과학회지
    • /
    • 제22권3호
    • /
    • pp.132-144
    • /
    • 2009
  • Objectives : The object of this literature study is to investigate the external treatment of seborrheic dermatitis. Methods : We have selected data related to the external treatment of seborrheic dermatitis on the literature of Oriental medicine. And we analyzed the study. Results : 1. The external treatment of seborrheic dermatitis is fundamental treatment. There are several external treatment, these are paint-treatment, shampoo-treatment and pillow-treatment. 2. Prescription used in external treatment of seborrheic dermatitis is Yungi-go(潤肌膏), Okgi-san(玉肌散), Yongnoe-go(龍腦膏), Johyub-tang(皂莢湯). 3. Herb used in external treatment of seborrheic dermatitis is Angelicae dahuricae Radix(白芷), Lysimachia foenumgraecum Hance(零陵香), Veratri Nigri Rhizoma Et Radix(藜蘆), Cannabis Fructus(大麻). Conclusions : Through literatual Study, we basically understood the external treatment of seborrheic dermatitis. In the study of external treatment, it seems that further clinical studies on seborrheic dermatitis treatment.

  • PDF

SD 랫드를 이용한 십전대보탕의 급성 독성 연구 (Acute Toxicity Study on Sipjeondaebo-tang in Rats)

  • 마진열;황대선;이남헌;하혜경;유영법;신현규
    • 동의생리병리학회지
    • /
    • 제22권5호
    • /
    • pp.1192-1195
    • /
    • 2008
  • Sipjeondaebo-tang has been traditionally prescribed a medicine as a restorative. In this study, we investigated the acute toxicity about water-extracted Sipjeondaebo-tang. Thirty rats completed 14 days of oral Sipjeondaebo-tang at the respective doses of 0(control group), 2000 and 5000 mg/kg. We observed survival rates, general toxicity, change of body weight and autopsy. To be confirmed the data for the toxicity and safety problems of oriental medicine prescription. Compared with the control group, we could not find any toxic alteration in all treated groups (2000 and 5000 mg/kg). LD50 of Sipjeondaebo-tang was over 5000 mg/kg and it is very safe to SD rats.

Improved Regenerative Responses of Injured Spinal Cord Nerve Fibers by the Treatment of Sukjihwang(Rehmanniae radix preparat)

  • Han, Kyu-Sul;Seol, In-Chan;Ryu, Ho-Ryong;Jo, Hyun-Kyung;An, Jung-Jo;NamGung, Uk;Kim, Yoon-Sik
    • 동의생리병리학회지
    • /
    • 제21권6호
    • /
    • pp.1569-1575
    • /
    • 2007
  • In oriental medicine, Sukjihwang (SJH, Rehmanniae radix preparat) has been used as one of the key ingredients for the prescription of several herbal decoctions and applied clinically for the treatment of several diseases including nervous system and cardiovascular disease. Here, possible growth-promoting effects of SJH on injured spinal cord axons were investigated in the rats. SJH administration increased levels of active form of ERK1/2 protein and Cdc2 proteins in the injured spinal cord tissue. Anterograde DiI-tracing of corticospinal tract axons showed that SJH-treatment enhanced axonal arborization in the injury area and extensive axonal extension into the caudal area. In SJH-treated group, glial scar formed after spinal cord injury was confined in a smaller area compared to the control group, and the trabecula structure was well observed within the injury cavity. Furthermore, increased proliferation and migration of astrocytes in the injury cavity were observed by SJH treatment. Thus, these present data provide a biological evidence on potential importance of SJH therapy for the treatment of injured spinal cord.

한의학 전통 지식 데이터베이스 관리 시스템 현황 (Currently Provided Database Management System of Traditional Korean Medical Knowledge)

  • 김현호;임진웅;박영재;박영배
    • 대한한의진단학회지
    • /
    • 제16권3호
    • /
    • pp.23-32
    • /
    • 2012
  • Objectives: The objective of this study is to investigate and valuate currently provided database management systems (DBMS) of traditional Korean medical knowledge. Methods: We searched DBMS on the web and smart device application markets (Apple App Store and Google Play Store). Key words for searching were 'traditional medicine', 'acupuncture', 'moxibustion', 'herbal medicine', and '한의학'. We looked into each DBMS to find out its scopes and limits, and each was valuated according to its functionality, accessibility, and utility. Results: 186 DBMS of traditional Korean medical knowledge were investigated and 91% of them were applications for smart devices. Almost all DBMS provided acupuncture and herb information, and a small amount of DMBS provided prescription and research paper information. Functionality, accessibility, and utility valuation were performed by using scoring system from 0 to 2. Mean values of functionality, accessibility, and utility were 0.86, 1.29, and 1.09. Conclusions: On the whole, high accessibility and low functionality were found, and various data-calculating functions were not implemented. Further researches and developments about traditional Korean medical knowledge DBMS are necessary to provide correct traditional Korean medical information and to support the studies about Korean medicine.

일개 한방병원에 파킨슨병으로 내원한 환자의 사상의학적 특성에 관한 고찰 (The Analysis on Characteristics according to Sasang Constitution of Patients with Parkinson's Disease in a Korean Medicine Hospital)

  • 김소형;이슬;이용재;배나영;이정윤
    • 사상체질면역의학회지
    • /
    • 제30권3호
    • /
    • pp.62-73
    • /
    • 2018
  • Objectives The aim of this study was to make an analysis of clinical characteristics and status of Sasang constitutional medicine of patients with Parkinson's Disease who visited a Korean medicine hospital. Methods We studied 129 patients with Parkinson's Disease who visited a Korean medicine hospital from September 1, 2012 to June 30, 2018. We retrospectively collected medical history and characteristics of subjects using data of EMR (electronic medical record). Results The proportion of female was higher than male. The average age was 60s. The patients visited a hospital more than one year after the occurrence of symptoms. And they were mostly under western medicine treatment. Among the 129 patients, 56 persons(43.4%) were Taeeumin, 45 persons(34.9%) Soyangin and 28 persons Soeumin(21.7%). In the distribution of prescription according Sasang Constitutional Medicine symptomatology, there was no significant difference in the proportion of exterior cold disease(48.9%) and interior heat disease(51.1%) in Soyangin. Meanwhile the proportion of heat disease's prescription was higher than cold disease in Taeeumin(73.2%) and Soeumin(84.1%). The majority of disease were Dry-febrile symptom(73.2%) of heat disease in Taeeumin, Yang depletion-syndrome(64.3%) of heat disease in Soeumin, and Gyolhyung-symptom(33.3%) of exterior cold disease and Wasting thirst-syndrome(22.2%) of interior heat disease in Soyangin, Conclusions By Developing of guideline for treatment of Parkinson's Disease through analyzing on clinical characteristics and distribution of Sasang Constitutional Medicine symptomatology could contribute to the improvement of the cure rate and accuracy of constitution pattern.

가미혈부축어탕 Hexane층의 항혈전활성과 뇌손상 보호효과 (Antithrombotic Activity and Protective Effects of hexane fraction of Kamihyulbuchukeotang (KHBCT) on brain injury by KCN and MCA occlusion)

  • 이민섭;노석선;임낙철;송호철;신순식;김성훈
    • 생약학회지
    • /
    • 제31권4호
    • /
    • pp.373-382
    • /
    • 2000
  • This study was performed to investigate the antithrombotic activity and protective effect of hexane fraction of Kamihyulbuchukeotang (KHCTH) on brain injury by KCN and MCA occlusion a prescription of HCT added with Lumbricus and Notoginseng Radix. Experiemental parameters are brain ischemia by MCA occlusion assay, KCN-induced brain injury, pulmonary thrombosis and platelet aggregation assay. The results were summarized as follows; 1. KHCTH extracts significantly inhibited the duration of KCN-induced coma (67%) and mortality (80%). 2. KHCTH extracts significantly suppressed brain ischemic area and edema following MCA occlusion and protected neuron cells as compared with control data. 3. KHCTH extracts inhibited pulmonary thrombosis induced by collagen and epinephrine. 4. KHCTH extracts inhibited platelet aggregation induced by collagen, ADP as agonist up to 76.9% and 32.3% respectivey at 1 mg/ml more effective than water extract of KHCT These data suggested that KHCTH could be applied as the protector of brain ischemia and injury and antithrombotic agent.

  • PDF

우리나라 의약품 경제성평가의 현황과 과제 (Current State and Challenges of Pharmacoeconomic Evaluation in Korea)

  • 최상은
    • Journal of Preventive Medicine and Public Health
    • /
    • 제41권2호
    • /
    • pp.74-79
    • /
    • 2008
  • Since the positive listing system for prescription drug reimbursement has been introduced in Korea, the number of pharmacoeconomic evaluation studies has increased. However it is not clear if the quality of pharmacoeconomic evaluation study has improved. Due to the lack of randomized clinical studies in Korean health care setting, Korean economic evaluation studies have typically integrated the local cost data and foreign clinical data. Therefore methodological issues can be raised in regard to data coherence and consistency. But the quality of data was not questiened and the potential bias has not been investigated yet. Even though changes in policy have encouraged the undertaking of pharmacoeconomic evaluations, there is few public-side funding for validation study of cost-effectiveness models and data. Several companies perform economic evaluation studies to be submitted on behalf of their own products, but do not want the study results to be disclosed to the academic community or public. To improve the present conduct of pharmacoeconomic evaluations in Korea, various funding sources need to be developed, and, like other multidisciplinary areas, the experts in different fields of study should collaborate to ensure the validity and credibility of pharmacoeconomic evaluations.